Cleo Diagnostics Past Earnings Performance
Past criteria checks 0/6
Cleo Diagnostics's earnings have been declining at an average annual rate of -117.4%, while the Medical Equipment industry saw earnings growing at 8.3% annually.
Key information
-117.4%
Earnings growth rate
51.3%
EPS growth rate
| Medical Equipment Industry Growth | 5.8% |
| Revenue growth rate | n/a |
| Return on equity | -40.0% |
| Net Margin | -1,783.2% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Revenue & Expenses Breakdown
How Cleo Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 0 | -4 | 1 | 3 |
| 31 Mar 24 | 0 | -4 | 1 | 2 |
| 31 Dec 23 | 0 | -4 | 1 | 2 |
| 30 Sep 23 | 0 | -3 | 1 | 1 |
Quality Earnings: COV is currently unprofitable.
Growing Profit Margin: COV is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if COV's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare COV's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: COV is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (18.7%).
Return on Equity
High ROE: COV has a negative Return on Equity (-40.03%), as it is currently unprofitable.